About admin

This author has not yet filled in any details.
So far admin has created 11 blog entries.

Prescription Painkillers Seen as a Gateway to Heroin

A recent article by the New York Times looks at the often-overlooked connection between the abuse of prescription painkillers, such as hydrocodone and oxycodone, and later heroin use. Read more from the New York Times here.

By | 2014-02-17T22:08:55+00:00 February 17th, 2014|Uncategorized|Comments Off on Prescription Painkillers Seen as a Gateway to Heroin

The Influence of Out-of-Pocket Costs on Cancer Treatment Adherence

A researcher publishing in the Journal of Clinical Oncology has found that patients with higher copayments were 70% more likely to stop taking Gleevec (imatinib) for their cancer, and patients were 42% more likely to skip doses entirely.   Noting the importance of adherence for patients with chronic myeloid leukemia (CML), which drugs like Gleevec [...]

By | 2014-01-22T21:12:33+00:00 January 22nd, 2014|Uncategorized|Comments Off on The Influence of Out-of-Pocket Costs on Cancer Treatment Adherence

College Students Tweeting About Adderall

Brigham Young University Researchers examined the Twitter feeds of the university's students for mentions of the stimulant ADHD medication Adderall. They found 213,633 tweets from 132,099 unique users that mentioned the drug over a 6 month period. Students were most likely to mention the drug during exam periods, with mentions highest in the US Northeast [...]

By | 2014-01-24T23:20:21+00:00 January 22nd, 2014|ADHD|Comments Off on College Students Tweeting About Adderall

New Opioid Receptor Targeted for Improved Pain and Addiction Treatment

Scientists writing in the Journal of Biological Chemistry have identified a new opioid receptor that may allow for more targeted pain and addiction treatments. Drugs targeting the kappa opioid receptor (KOR) would have the potential to increase therapeutic effects and minimize harmful side effects.   Read more here. 

By | 2014-01-22T16:18:14+00:00 January 21st, 2014|Uncategorized|Comments Off on New Opioid Receptor Targeted for Improved Pain and Addiction Treatment

Electronic Monitoring and Medication Adherence in Clinical Trials

The use of electronic monitoring was found to greatly improve medication adherence tracking over self-report alone in a clinical trial published in the journal Inflammatory Bowel Diseases. Researchers who conducted the study concluded that “In clinical studies involving patients with long-term chronic conditions, researchers should strongly consider collecting medication adherence data electronically, particularly where patients are [...]

By | 2014-01-22T16:30:47+00:00 January 21st, 2014|Uncategorized|Comments Off on Electronic Monitoring and Medication Adherence in Clinical Trials

Risk Communication in Chronic Opioid Therapy

A recent study published in the journal Patient Education and Counseling is among the first to examine how patients and primary care physicians discuss the risks of chronic opioid therapy, finding that a stronger therapeutic relationship was related to more thorough discussions.   Read more here.

By | 2014-01-22T16:32:51+00:00 January 16th, 2014|Uncategorized|Comments Off on Risk Communication in Chronic Opioid Therapy

Zohydro ER Receives FDA Approval

One day after recommending that hydrocodone-containing products be reclassified as more restricted Schedule II drugs, the FDA has approved Zohydro ER, the first hydrocodone-only formulation drug, developed by San Diego-based company Zogenix. The FDA's press release can be found here.

By | 2014-01-09T17:42:48+00:00 October 28th, 2013|Uncategorized|Comments Off on Zohydro ER Receives FDA Approval

FDA Recommends Reclassifying Hydrocodone Products

On Thursday the FDA recommended to the U.S. Department of Health and Human Services that hydrocodone containing drugs such as Vicodin be reclassified as Schedule II, rather than Schedule III drugs. The New York times has also reported on this substantial move by the FDA.  

By | 2014-01-09T17:46:50+00:00 October 24th, 2013|Uncategorized|Comments Off on FDA Recommends Reclassifying Hydrocodone Products